Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-obesity drugs: past, present and future
R.J. Rodgers, Matthias H. Tschöp, John Wilding
Disease Models & Mechanisms (2012) Vol. 5, Iss. 5, pp. 621-626
Open Access | Times Cited: 418

Showing 1-25 of 418 citing articles:

A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
Brian Finan, Bin Yang, Nickki Ottaway, et al.
Nature Medicine (2014) Vol. 21, Iss. 1, pp. 27-36
Closed Access | Times Cited: 556
Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease
Connor A. Emdin, Amit V. Khera, Pradeep Natarajan, et al.
JAMA (2017) Vol. 317, Iss. 6, pp. 626-626
Open Access | Times Cited: 350
Serotonin controlling feeding and satiety
Jörg‐Peter Voigt, Heidrun Fink
Behavioural Brain Research (2014) Vol. 277, pp. 14-31
Open Access | Times Cited: 279
Pursuit of a perfect insulin
Alexander N. Zaykov, John P. Mayer, Richard D. DiMarchi
Nature Reviews Drug Discovery (2016) Vol. 15, Iss. 6, pp. 425-439
Closed Access | Times Cited: 263
Antiobesity carbonic anhydrase inhibitors: a literature and patent review
Andrea Scozzafava, Claudiu T. Supuran, Fabrizio Carta
Expert Opinion on Therapeutic Patents (2013) Vol. 23, Iss. 6, pp. 725-735
Closed Access | Times Cited: 260
Adipokines – removing road blocks to obesity and diabetes therapy
Matthias Blüher
Molecular Metabolism (2014) Vol. 3, Iss. 3, pp. 230-240
Open Access | Times Cited: 252
Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
Assumpta Caixàs, Lara Albert, Ismael Capel, et al.
Drug Design Development and Therapy (2014), pp. 1419-1419
Open Access | Times Cited: 230
Altered gut and adipose tissue hormones in overweight and obese individuals: cause or consequence?
MEJ Lean, Dalia Malkova
International Journal of Obesity (2015) Vol. 40, Iss. 4, pp. 622-632
Open Access | Times Cited: 217
Unimolecular Polypharmacy for Treatment of Diabetes and Obesity
Matthias H. Tschöp, Brian Finan, Christoffer Clemmensen, et al.
Cell Metabolism (2016) Vol. 24, Iss. 1, pp. 51-62
Open Access | Times Cited: 216
Microbial metabolites in nutrition, healthcare and agriculture
Rajendra Singh, M. Kumar, Anshumali Mittal, et al.
3 Biotech (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 206
Weight Management in Type 2 Diabetes: Current and Emerging Approaches to Treatment
Luc Van Gaal, André Scheen
Diabetes Care (2015) Vol. 38, Iss. 6, pp. 1161-1172
Open Access | Times Cited: 205
Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice
Jaemin Lee, Junli Liu, Xudong Feng, et al.
Nature Medicine (2016) Vol. 22, Iss. 9, pp. 1023-1032
Open Access | Times Cited: 192
Natural Products with Anti-obesity Effects and Different Mechanisms of Action
Chuhan Fu, Yao Jiang, Jiao Guo, et al.
Journal of Agricultural and Food Chemistry (2016) Vol. 64, Iss. 51, pp. 9571-9585
Closed Access | Times Cited: 184
Obesity: Current and potential pharmacotherapeutics and targets
Vidya Narayanaswami, Linda P. Dwoskin
Pharmacology & Therapeutics (2016) Vol. 170, pp. 116-147
Open Access | Times Cited: 171
Biological Properties and Bioactive Components of Allium cepa L.: Focus on Potential Benefits in the Treatment of Obesity and Related Comorbidities
Mariangela Marrelli, Valentina Amodeo, Giancarlo Statti, et al.
Molecules (2018) Vol. 24, Iss. 1, pp. 119-119
Open Access | Times Cited: 166
Anti-Obesity Therapy: from Rainbow Pills to Polyagonists
Timo D. Müller, Christoffer Clemmensen, Brian Finan, et al.
Pharmacological Reviews (2018) Vol. 70, Iss. 4, pp. 712-746
Open Access | Times Cited: 162
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database
Mansour Tobaiqy, Hajer Elkout
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 2, pp. 488-495
Open Access | Times Cited: 31
Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database
Rosanna Ruggiero, Annamaria Mascolo, Angela Spezzaferri, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 147-147
Open Access | Times Cited: 18
Functional food ingredients for the management of obesity and associated co-morbidities – A review
Ritesh K. Baboota, Mahendra Bishnoi, Padma Ambalam, et al.
Journal of Functional Foods (2013) Vol. 5, Iss. 3, pp. 997-1012
Closed Access | Times Cited: 164
Evolution of pharmacological obesity treatments: focus on adverse side‐effect profiles
Andrew J. Krentz, Ken Fujioka, Marcus Hompesch
Diabetes Obesity and Metabolism (2016) Vol. 18, Iss. 6, pp. 558-570
Closed Access | Times Cited: 154
Role of adipokines and cytokines in obesity-associated breast cancer: Therapeutic targets
Sajid Khan, Samriddhi Shukla, Sonam Sinha, et al.
Cytokine & Growth Factor Reviews (2013) Vol. 24, Iss. 6, pp. 503-513
Closed Access | Times Cited: 152
Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review
Igho Onakpoya, Carl Heneghan, Jeffrey K Aronson
BMC Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 150
Functional foods as potential therapeutic options for metabolic syndrome
Lindsay Brown, Hemant Poudyal, Sunil K. Panchal
Obesity Reviews (2015) Vol. 16, Iss. 11, pp. 914-941
Closed Access | Times Cited: 146
Ursolic Acid Inhibits Adipogenesis in 3T3-L1 Adipocytes through LKB1/AMPK Pathway
Yonghan He, Ying Li, Tiantian Zhao, et al.
PLoS ONE (2013) Vol. 8, Iss. 7, pp. e70135-e70135
Open Access | Times Cited: 136
The evolution of human adiposity and obesity: where did it all go wrong?
Jonathan C. K. Wells
Disease Models & Mechanisms (2012) Vol. 5, Iss. 5, pp. 595-607
Open Access | Times Cited: 123
Page 1 - Next Page

Scroll to top